Cytokinetics stock garners strong analyst support with high growth potential. Click here to find out why the CYTK's pipeline ...

Q2 2025 Earnings Call Transcript July 24, 2025 Lazard Ltd beats earnings expectations. Reported EPS is $0.52, expectations ...

A few major customers account for a substantial amount of Sonoco's revenue. They tend to have bargaining power, and if one of them were to switch to another packaging provider, it would have a ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...

From AI integration to workforce development, health system marketing leaders are making targeted investments in 2025 aimed at boosting engagement, strengthening strategy alignment and driving ...

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

Q2 2025 Earnings Call Transcript July 23, 2025 Thermo Fisher Scientific Inc. beats earnings expectations. Reported EPS is ...

The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea ...

Casper claimed that during the quarter, Thermo Fisher advanced its growth strategy, launching a range of high-impact ...